InMed Pharmaceuticals's total assets for Q4 2024 were $11.82M, a decrease of -11.50% from the previous quarter. INM total liabilities were $2.62M for the fiscal quarter, a 16.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.